title: A retrospective controlled analysis of outcomes of using integrated therapy of traditional Chinese and modern medicines for primary liver cancer of middle and late stages.
authors.forename: Zhe
authors.initials: Z
authors.lastname: Chen
authors.forename: Bai
authors.initials: B
authors.lastname: Li
authors.forename: Xiaoqiang
authors.initials: X
authors.lastname: Yue
authors.forename: Dezeng
authors.initials: D
authors.lastname: Zhu
authors.forename: Chaoquin
authors.initials: C
authors.lastname: Yu
authors.forename: Mengchao
authors.initials: M
authors.lastname: Wu
authors.forename: Chanquan
authors.initials: C
authors.lastname: Ling
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy / Q000628:therapy*; D016461:Chemoembolization, Therapeutic; D003131:Combined Modality Therapy; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy / Q000628:therapy*; D012189:Retrospective Studies; D016896:Treatment Outcome
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D004365:Drugs, Chinese Herbal